Absorption Pharmaceuticals

Absorption Pharmaceuticals is a consumer healthcare company specializing in the development and commercialization of sexual wellness products. The company is best known for its flagship product, Promescent, a topical lidocaine-based spray designed to treat premature ejaculation through a proprietary absorption technology. This technology allows the medication to penetrate the stratum corneum of the skin, providing localized desensitization while minimizing transfer to sexual partners. In 2017, the company was acquired by Veru Inc., a biopharmaceutical company focused on oncology and sexual health. Today, Absorption Pharmaceuticals operates as a subsidiary, offering a range of over-the-counter products including sprays, lubricants, and supplements.